Qube Research & Technologies (QRT)
PRAX icon

Qube Research & Technologies (QRT)’s Praxis Precision Medicines PRAX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$51M Buy
152,475
+24,247
+19% +$7.68M 0.05% 490
2026
Q1 		$41.3M Sell
128,228
-40,669
-24% -$12.6M 0.05% 506
2025
Q4 		$49.8M Buy
168,897
+111,593
+195% +$20.8M 0.05% 499
2025
Q3 		$3.04M Buy
+57,304
New +$2.78M ﹤0.01% 2020
2025
Q1 		– Sell
-31,999
Closed -$2.46M – 3799
2024
Q4 		$2.46M Sell
31,999
-12,704
-28% -$919K ﹤0.01% 1798
2024
Q3 		$2.57M Sell
44,703
-45,990
-51% -$2.48M ﹤0.01% 1677
2024
Q2 		$3.75M Sell
90,693
-42,249
-32% -$2M 0.01% 1392
2024
Q1 		$8.11M Buy
132,942
+107,838
+430% +$4.84M 0.01% 960
2023
Q4 		$559K Buy
25,104
+25,082
+114,009% +$452K ﹤0.01% 2219
2023
Q3 		$566 Sell
22
-5,027
-100% -$95.1K ﹤0.01% 3670
2023
Q2 		$87.1K Buy
+5,049
New +$77.3K ﹤0.01% 1972
2022
Q4 		– Sell
-2,315
Closed -$79K – 2883
2022
Q3 		$79K Buy
+2,315
New +$115K ﹤0.01% 2036

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRAX Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Praxis Precision Medicines (PRAX) stake by 19% in Q2 2026, buying an estimated $7.68M and bringing the position to 152,475 shares worth $51M. The position accounts for 0.05% of the portfolio, ranked #490.

Qube Research & Technologies (QRT) first reported a position in PRAX in Q3 2022 and has held it in 12 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Qube Research & Technologies (QRT) held 152,475 shares of Praxis Precision Medicines worth $51M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 24,247 Praxis Precision Medicines shares in Q2 2026, an estimated $7.68M.
  • Praxis Precision Medicines made up 0.05% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #490 holding.
  • Qube Research & Technologies (QRT) first reported a position in Praxis Precision Medicines in Q3 2022 and has held it in 12 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.